Furst DE, Khanna D. (Am J Manag Care. 2007;13[suppl 9]:S216-S217.
Tugwell P, Idzerda L, Wells GA. (Am J Manag Care. 2007; 13[suppl 9]:S224-S236.
Strand V, Singh JA. (Am J Manag Care. 2007;[suppl 9]:S237-S251.
Improved Health-related Quality of Life With Effective Disease-modifying Antirheumatic Drugs: Evidence From Randomized Controlled Trials
Characteristics of and Trends in the Late-stage Biopharmaceutical Pipeline
Research on characteristics of the biopharmaceutical pipeline and on changes since 2003 includes a description of new features and recommendations for health policy decision makers.
Furst, DE; Khanna, D. (Am J Manag Care. 2007;13[suppl 9]:S216-S217)
Tugwell P, Idzerda L, Wells GA. (Am J Manag Care. 2007;13[suppl 9]:S224-S236)
Strand V, Singh JA. (Am J Manag Care. 2007;13[suppl 9]:S237-S251)
Asthma-specific Quality of Life and Subsequent Asthma Emergency Hospital Care
Asthma-specific quality of life and a history of acute episodes can be used together to identify risks of subsequent acute exacerbations.
Does Sharing Care Across the Primary–Specialty Interface Improve Outcomes in Chronic Disease? A Systematic Review
Evidence to support the introduction of shared care services into clinical practice is limited, although methodologic shortcomings may account for this lack of evidence.
Association of Insurance Coverage With Chlamydia Screening
Among young, sexually active women, self-reported Chlamydia trachomatis screening rates were primarily influenced by risk factors rather than insurance coverage.
A Strategic Plan for Integrating Cost-effectiveness Analysis Into the US Healthcare System
A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Costs of Treating Lower Respiratory Tract Infections
Compared with other costs of treatment, expenditures for antibiotics were nominal in an adult primary care population with lower respiratory tract infections.
